Evaluation of a novel signature for PARP inhibitor sensitivity prediction using real-world data

被引:0
|
作者
Vucic, Emily [1 ]
Kuperwaser, Felicia [1 ]
Kumar, Sunil [1 ]
Tracy, Dillon [1 ]
Marchenko, Olena [1 ]
Miao, Zong [1 ]
Kaffey, Jacob [1 ]
Pindak, Samantha [1 ]
Tann, Nathaniel [1 ]
Wolinsky, Jordan [1 ]
Klei, Sean [1 ]
Chursov, Andrey [1 ]
Khan, Fahad [1 ]
Rouly, Jean Michel [1 ]
Komatsoulis, George Anthony [1 ]
Sherman, Jeff [1 ]
Baron, Maayan [1 ]
机构
[1] Zephyr AI, Mclean, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5583
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Data integration for earthquake disaster using real-world data
    Tian, Chuanzhao
    Li, Guoqing
    ACTA GEOPHYSICA, 2020, 68 (01) : 19 - 28
  • [42] Beyond data sharing: Using real-world data for teaching real-world computational workflows and for benchmarking new methods
    Jansen, Johanna
    Amaro, Rommie
    Tseng, Y. Jane
    Cornell, Wendy
    Esposito, Emilio
    Walters, Pat
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [43] ASSESSMENT OF REAL-WORLD DATA SOURCES AND A HYBRID APPROACH IN REAL-WORLD EVIDENCE GENERATION USING UNHARMONIZED DATA SOURCES
    Toh, K. C.
    Goh, C. H.
    Goh, V
    Dong, Z.
    Dumpala, L. S.
    Maity, S.
    Wu, J. Y.
    Kleinman, N.
    Lee, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S407 - S407
  • [44] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
  • [45] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [46] From real-world electronic health record data to real-world results using artificial intelligence
    Knevel, Rachel
    Liao, Katherine P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03) : 306 - 311
  • [47] Conundrum of Using Real-World Observational Data to Inform Real-World Conclusions About Safety and Efficacy
    Gibson, C. Michael
    Nafee, Tarek
    Kerneis, Mathieu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) : 1801 - 1803
  • [48] Real-world evaluation of TNF-inhibitor utilization in rheumatoid arthritis
    Harnett, J.
    Wiederkehr, D.
    Gerber, R.
    Gruben, D.
    Koenig, A.
    Bourret, J.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (02) : 91 - 102
  • [49] Room for growth: Real-world maintenance and treatment PARP inhibitor use in BRCAm ovarian cancer patients
    Lee, Sarah
    Smith, Maria
    Monestime, Gianina
    Pothuri, Bhavana
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S268 - S269
  • [50] PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience
    Agarwal, Amit
    Baghmar, Saphalta
    Dodagoudar, Chandragouda
    Qureshi, Suhail
    Khurana, Aseem
    Vaibhav, Vikas
    Kumar, Guresh
    JCO GLOBAL ONCOLOGY, 2021, 7 : 506 - 511